# Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

> **NCT04199026** · NA · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Metastatic Sarcoma
- Recurrent Sarcoma
- Resectable Sarcoma

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Doxorubicin Hydrochloride
- **DEVICE:** Drug Delivery Microdevice
- **DRUG:** Everolimus
- **BIOLOGICAL:** Ganitumab
- **DRUG:** Ifosfamide
- **DRUG:** Irinotecan
- **DRUG:** Pazopanib
- **DRUG:** Polyethylene Glycol
- **DRUG:** Temozolomide
- **DRUG:** Temsirolimus
- **PROCEDURE:** Therapeutic Conventional Surgery
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT04199026
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199026, "Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04199026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*